| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |